Gas recuperative flameless thermal oxidizer
    1.
    发明申请
    Gas recuperative flameless thermal oxidizer 审中-公开
    气体回热无焰热氧化剂

    公开(公告)号:US20060084017A1

    公开(公告)日:2006-04-20

    申请号:US10966533

    申请日:2004-10-15

    IPC分类号: F23D3/40

    摘要: The invention provides a gas recuperative flameless thermal oxidizer. The oxidizer includes a matrix bed and at least one feed passage extending at least partially within the matrix bed. The feed passage has an inlet configured to receive combustible vapor or an air-combustible vapor mixture and an outlet configured to deliver the combustible vapor or the air-combustible vapor mixture into the matrix bed. The feed passage has a cross-sectional area and a length within the matrix bed, wherein a ratio of the length (ft) to the cross-sectional area (in2) is at least about 0.5:1.

    摘要翻译: 本发明提供了一种气体再生无火焰热氧化剂。 氧化剂包括基质床和至少部分地在基质床内延伸的至少一个进料通道。 进料通道具有构造成接收可燃蒸汽或空气可燃蒸气混合物的入口和被配置为将可燃蒸气或空气可燃蒸汽混合物输送到基质床中的出口。 进料通道具有在基质床内的横截面积和长度,其中长度(ft)与横截面积(在 2)中的比率为至少约0.5:1 。

    Genetically engineered P30 antigen improved antigen cocktail, and uses thereof
    3.
    发明申请
    Genetically engineered P30 antigen improved antigen cocktail, and uses thereof 有权
    遗传工程化的P30抗原改良抗原鸡尾酒及其应用

    公开(公告)号:US20060105451A1

    公开(公告)日:2006-05-18

    申请号:US11316532

    申请日:2005-12-21

    IPC分类号: C12N15/74 C07H21/04

    摘要: The present invention relates to a genetically engineered P30 antigen and a combination or mixture of antigens (e.g., the genetically engineered P30 antigen and P35) that may be used in the detection of IgM and/or IgG antibodies to Toxoplasma gondii. Furthermore, the present invention also relates to methods of using this genetically engineered P30 antigen and combination of antigens, antibodies raised against this genetically engineered P30 antigen and combination of antigens, as well as kits and vaccines containing the genetically engineered P30 antigen and antigens present in the combination.

    摘要翻译: 本发明涉及可用于检测弓形虫的IgM和/或IgG抗体的遗传工程化的P30抗原和抗原(例如,遗传工程化的P30抗原和P35)的组合或混合物。 此外,本发明还涉及使用这种遗传工程化的P30抗原和抗原组合,针对该遗传工程化的P30抗原产生的抗体和抗原组合的方法,以及含有遗传工程化的P30抗原的试剂盒和疫苗以及存在于 组合。